| A systematic profile of DNA methylation in human cancer cell lines MF Paz, MF Fraga, S Avila, M Guo, M Pollan, JG Herman, M Esteller Cancer research 63 (5), 1114-1121, 2003 | 494 | 2003 |
| Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors MF Paz, S Avila, MF Fraga, M Pollan, G Capella, MA Peinado, ... Cancer research 62 (15), 4519-4524, 2002 | 309 | 2002 |
| The impact of MECP2 mutations in the expression patterns of Rett syndrome patients E Ballestar, S Ropero, M Alaminos, J Armstrong, F Setien, R Agrelo, ... Human genetics 116, 91-104, 2005 | 92 | 2005 |
| Synergistic effect of trabectedin and olaparib combination regimen in breast cancer cell lines S Ávila-Arroyo, GS Nuñez, LF García-Fernández, CM Galmarini Journal of breast cancer 18 (4), 329, 2015 | 25 | 2015 |
| Metabolomic connections between schizophrenia, antipsychotic drugs and metabolic syndrome: a variety of players JD Molina, S Avila, G Rubio, F López-Muñoz Current Pharmaceutical Design 27 (39), 4049-4061, 2021 | 19 | 2021 |
| Abstract A174: Comparison of the antitumor activity of Trabectedin, Lurbinectedin, Zalypsis and PM00128 in a panel of human cells deficient in transcription/NER repair factors. V Moneo, P Martínez, B de Castro, S Cascajares, S Avila, ... Molecular Cancer Therapeutics 12 (11_Supplement), A174-A174, 2013 | 4 | 2013 |
| Transactivation domains are not functionally conserved between vertebrate and invertebrate serum response factors S Avila, MC Casero, R Fernandez‐Cantón, L Sastre European journal of biochemistry 269 (15), 3669-3677, 2002 | 4 | 2002 |
| Synergistic combination of Trabectedin and Olaparib in breast cancer tumor cell lines S Avila, M Martínez, V Moneo, JF Martínez-Leal, C Cuevas, ... Cancer Research 74 (19_Supplement), 1686-1686, 2014 | 3 | 2014 |
| Estradiol and Progesterone as key modulators of central systems implicated in schizophrenia A Ruiz-Tristan, C Rivera-Clemente, V Gomez-De-Las-Heras, S Ávila, ... European Psychiatry 65 (S1), S734-S734, 2022 | 1 | 2022 |
| Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players. JD Molina Martín, S Ávila, G Rubio, F López Muñoz Current Pharmaceutical Design, 2022 | | 2022 |
| Synergistic combination of lurbinectedin and PARP inhibitors in breast cancer tumor cell lines G Santamaría, S Avila, V Moneo, C Cuevas, LF García-Fernández, ... Cancer Research 75 (15_Supplement), 2520-2520, 2015 | | 2015 |
| 57 Differential antitumor activity of trabectedin, lurbinectedin, Zalypsis and PM00128 against a panel of human cells deficient in transcription and NER factors V Moneo, S Avila, P Martínez, B de Castro, S Cascajares, C Cuevas, ... European Journal of Cancer, 24, 2014 | | 2014 |
| Comparison of the antitumor activity of Trabectedin, Lurbinectedin, Zalypsis and PM00128 in a panel of human cells deficient in transcription/NER repair factors. V Moneo, P Martinez, B de Castro, S Cascajares, S Avila, ... MOLECULAR CANCER THERAPEUTICS 12 (11), 2013 | | 2013 |
